Terumo Heart Reports Summary of DuraHeart(TM) LVAS Clinical Tri... ( ANN ARBOR Mich. Sept. 17 /- Terum...)

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> MEDICINE >> TECHNOLOGY

Terumo Heart Reports Summary of DuraHeart(TM) LVAS Clinical Trial Results

Date:9/17/2007

ANN ARBOR, Mich., Sept. 17 /PRNewswire/ -- Terumo Heart, Inc. announced today that it had a successful European Launch Symposium at the European Association of Cardio-Thoracic Surgeons (EACTS) meeting in Geneva, Switzerland.

(Logo: http://www.newscom.com/cgi-bin/prnh/20061027/DEF004LOGO )

(Logo: http://www.newscom.com/cgi-bin/prnh/20070227/CLTU043LOGO )

A summary of the European Clinical Trial results for the DuraHeart(TM) Left Ventricular Assist System (LVAS) was presented by Dr. Aly El-Banayosy from the Heart Center Nordrhein-Westfalen in Bad Oeynhausen, Germany, followed by the presentation "The Emerging New Era of Mechanical Circulatory Support," by Dr. Eric Rose of Columbia University Medical Center in New York.

The symposium highlighted the DuraHeart device, as well as the BioValsalva Aortic Valved Conduit developed by Vascutek Ltd, a Terumo Company.

A summary of DuraHeart LVAS clinical results to-date (as of September 15, 2007):

* Patients enrolled = 33

* Median age (years) = 57 (29-73)

* Mean support duration (days) = 231194 (range: 17-803)

* Cumulative support duration = 7610 days (> 20 years)

* 7 patients (21%) supported > 1 year, and one supported > 2 years.

* 12 patients (36%) remain on support with a mean duration > 1 year (375

196 days)

* Kaplan Meier survival at 1 and 2 years was: 77% (all patients), 80% (<65

yrs), 90% (<60 yrs) and 100% (<50)

Chisato Nojiri, M.D., Ph.D., Chief Executive Officer for Terumo Heart, Inc., said; "We have had a number of significant milestones this year, most importantly receiving the CE Mark and a successful commercial launch in Europe."

The interest from surgeons at the EACTS has been extremely good. Dr. Nojiri commented, "We have been very pleased w
'/>"/>

SOURCE Terumo Heart, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related medicine technology :

1. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
2. Lexicon Develops Antibodies That Lower Triglycerides and Cholesterol as Potential New Therapy for Heart Disease
3. Research Documents Scalable Production, Survival Following Engraftment and Positive Impact on Cardiac Function in Infarcted Rats for Gerons Human Embryonic Stem Cell-Based Therapeutic for Heart Failure
4. Treating Heart Disease Risk Factors May Slow Alzheimers Disease Progression
5. Pilot Phase 3 Results of NovaCardias KW-3902 for Acute Congestive Heart Failure Presented at Late-Breaking Session of Heart Failure Congress 2007
6. Drug for Treatment of Heart Failure Does Not Improve Survival, Compared to More Widely-used Medication
7. deCODE Announces Positive Topline Results for Phase I Study of DG051 for the Prevention of Heart Attack
8. Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events in Landmark Jikei Heart Study
9. Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events in Landmark Jikei Heart Study
10. First Controlled Large-Scale Intervention Angiotensin Receptor Blocker (ARB) Trial in a Japanese Population, JIKEI HEART Study Demonstrates Significant Reduction in Blood Pressure and Protection of Organs with Valsartan
11. New Anti-Rejection Medication 6-Month Results for Heart Transplant Recipients to Be Released at International Heart and Lung Transplant Meeting

Post Your Comments:

(Date:5/24/2013)... -- BD (Becton, Dickinson and Company) (NYSE: BDX ), ... will present at the Deutsche Bank 38 th Annual ... a.m. (ET). A live webcast of BD,s ... www.bd.com/investors and will be available for replay through ... BD is a leading global medical technology company that ...

(Date:5/24/2013)... 2013 Solta Medical, Inc. (NASDAQ: SLTM ... reported Dr. Edward W. Knowlton has ... effective immediately. Dr. Knowlton is the founder of Thermage, the ... director since 1996. "On behalf of the entire ... would like to thank Ed for his tireless dedication to ...

(Date:5/24/2013)... , May 24, 2013 Heska Corporation (NASDAQ: HSKA, ... and specialty products, announced today that Dr. Robert ... and Jason Napolitano , executive vice president ... Marcum MicroCap Conference, which is being held May 30, 2013 ... Grand Hyatt Hotel. The Company,s presentation is ...

Breaking Medicine Technology:Dr. Edward W. Knowlton Resigns as a Director of Solta Medical, Inc. 2 Heska Corporation To Present At The Second Annual Marcum LLP MicroCap Conference 2

[0] BD to Present at the Deutsche Bank 38th Annual Health Care Conference [0] Dr. Edward W. Knowlton Resigns as a Director of Solta Medical, Inc.[0] Heska Corporation To Present At The Second Annual Marcum LLP MicroCap Conference

... to a new market research report " ... (ICs, Thermostat, Thermistor, Resistive Temperature Detectors (RTDs), Thermocouple) & ... " published by MarketsandMarkets ( http://www.marketsandmarkets.com ), the ... was $3.27 billion and is expected to reach $4.51 ...

... 29, 2012 Cempra, Inc. (NASDAQ: CEMP ) ... and chief executive officer, will present at the Cowen ... a.m. EST, March 6, 2012, at The Boston Marriott ... overview of the company,s two leading antibiotic clinical programs, ...

Cached Medicine Technology:MarketsandMarkets: Global Temperature Sensors Market Worth $4.51 Billion by 2016 2 MarketsandMarkets: Global Temperature Sensors Market Worth $4.51 Billion by 2016 3 Cempra, Inc. to Present at the Cowen and Company 32nd Annual Health Care Conference 2

MarketsandMarkets: Global Temperature Sensors Market Worth $4.51 Billion by 2016 Cempra, Inc. to Present at the Cowen and Company 32nd Annual Health Care Conference

(Date:5/25/2013)... May 25 (HealthDay News) -- Many viruses and parasites ... and leptospirosis -- a bacteria-borne illness than can result ... at dog parks, according to a veterinarian. ... and even the air, said Dr. Susan Nelson, a ... Center. "Many of these serious diseases can be fatal, ...

(Date:5/25/2013)... May 25, 2013 Providing patients with their ... Doc team of weight management professionals. But, aside from educating ... effectively, Diet Doc’s hCG diets also provide patients, ... during childhood like bullying, more control over their lives by ... dealing with the underlying factors of weight gain derived from ...

(Date:5/25/2013)... New York,NY (PRWEB) May 25, 2013 ... SizeItUp officially declared the integration of the 2012 ... Lamborghini Aventador is the latest entrant in the list ... Designed intelligently, the vehicle is all set to thrill ... with vicious acceleration power and spectacular looks, the 2012 ...

(Date:5/25/2013)... BC (PRWEB) May 25, 2013 According ... the most beautiful and powerful women that ever lived. ... felt by some of the most powerful men in ... many beauty remedies to keep her skin glowing and ... made with bees- wax, maringa oil and cyprus grass. ...

(Date:5/25/2013)... For college students, few events ... they are turning to prescription stimulants like Adderall ... more on this, go to http://www.sciencedaily.com/releases/2013/05/130501145151.htm . ... that students who pick up Adderall, “just to ... developing a physical and psychological dependency. While initially ...

Breaking Medicine News(10 mins):Health News:Hidden Dangers Dog Dog Parks 2 Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announces hCG Diet Plans for Those Suffering from Abuse-Related Weight Gain 2 Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announces hCG Diet Plans for Those Suffering from Abuse-Related Weight Gain 3 Health News:Rim Fitments Provider SizeItUp Launches The Database Integration For The 2012 Lamborghini Aventador 2 Health News:The Cleopatra Lift - A New Non Surgical Option to Aging Offered by Vancouver Physician 2 Health News:The Cleopatra Lift - A New Non Surgical Option to Aging Offered by Vancouver Physician 3 Health News:Addiction and Drug Abuse: Study Drug Adderall Abuse Spikes During Finals 2

[0] Hidden Dangers Dog Dog Parks [0] hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announces hCG Diet Plans for Those Suffering from Abuse-Related Weight Gain [0] Rim Fitments Provider SizeItUp Launches The Database Integration For The 2012 Lamborghini Aventador [0] The Cleopatra Lift - A New Non Surgical Option to Aging Offered by Vancouver Physician [0] Addiction and Drug Abuse: Study Drug Adderall Abuse Spikes During Finals

... Director of National Institutes of HealthNEW YORK, Feb. 3 ... the election of Dr. Elias A. Zerhouni , the ... leader in biomedical research, to its Board of Directors."We are ... of Directors," said Dr. Maria C. Freire , President ...

... to Chief Marketing Officer and PACS Industry Veteran ... ManagerWASHINGTON, Feb. 3 Compressus, Inc., leaders in ... team with the promotion of Janine Broda to ... Shawn Gibbons as vice president and general manager ...

... Feb. 3 The Female Health Company (NYSE Alternext: ... conference call to discuss its operating results for the ... (EST) on Tuesday, February 10, 2009. The Company ... the same day. Shareholders and other interested parties may ...

... Go Healthy, Inc. (Pink Sheets: GOHE) announced today that ... for development of major sports relationships at meetings held ... developing partnership with a sports entity, whose members are ... are a major extension of our agreement with Athletic ...

... the best way of spotting trouble, experts say , , ... the stool-based colon cancer tests -- recommended annually for ... to spot potential abnormalities, a German study finds. , ... tests for what is called fecal occult blood -- ...

... ALLEGAN, Mich., Feb. 3 Perrigo Company,(Nasdaq: PRGO ; TASE) today announced results for its fiscal year 2009 second,quarter and six months that ended December 27, ... Perrigo Company, ... Second Quarter Six Months, ... 2009 2008 2009 ...

Lasker Foundation Welcomes Elias Zerhouni to Board of Directors Compressus Bolsters Executive Team to Expand Interoperability Market Pioneered by MEDxConnect(TM)The Female Health Company Schedules First Quarter Conference Call for February 10, 2009 Go Healthy Participates in Super Bowl Events and Developing Sports Relationships Stool-Based Colon Cancer Tests Vary Widely in Accuracy Perrigo Reports Record Second Quarter Sales

Unique supportive clavicle splint. Features front closure design for convenience in application. Comfortable padding over clavicle area....

Indicated for treatment of patella instability...

... and Cronin, Inc. is ... Patient Footwear, Orthopedic Softgoods, ... Products. Our products are ... and available in the ...

... pain relief, stabilization and comfort for patient ... ,The Aspen® "Low Profile" LSO provides immediate ... tightened, using the LeverLatch mechanism, the brace ... of functional mobility and, in many cases, ...

Medicine Products:

Front Closure Clavicle Support 13 Patella Stabilizer w/Cor-Trak Buttress Comfor™ Clavicle Brace - Buckle Closure Aspen® LSO